Your browser doesn't support javascript.
loading
Co-occurring Alterations in the RAS-MAPK Pathway Limit Response to MET Inhibitor Treatment in MET Exon 14 Skipping Mutation-Positive Lung Cancer.
Rotow, Julia K; Gui, Philippe; Wu, Wei; Raymond, Victoria M; Lanman, Richard B; Kaye, Frederic J; Peled, Nir; Fece de la Cruz, Ferran; Nadres, Brandon; Corcoran, Ryan B; Yeh, Iwei; Bastian, Boris C; Starostik, Petr; Newsom, Kimberly; Olivas, Victor R; Wolff, Alexander M; Fraser, James S; Collisson, Eric A; McCoach, Caroline E; Camidge, D Ross; Pacheco, Jose; Bazhenova, Lyudmila; Li, Tianhong; Bivona, Trever G; Blakely, Collin M.
Afiliación
  • Rotow JK; Department of Medicine, University of California, San Francisco, California.
  • Gui P; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California.
  • Wu W; Department of Medicine, University of California, San Francisco, California.
  • Raymond VM; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California.
  • Lanman RB; Department of Medicine, University of California, San Francisco, California.
  • Kaye FJ; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California.
  • Peled N; Guardant Health, Inc., Redwood City, California.
  • Fece de la Cruz F; Guardant Health, Inc., Redwood City, California.
  • Nadres B; Department of Medicine, University of Florida, Gainesville, Florida.
  • Corcoran RB; Soroka Medical Center, Ben-Gurion University, Beer-Sheva, Israel.
  • Yeh I; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.
  • Bastian BC; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.
  • Starostik P; Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts.
  • Newsom K; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California.
  • Olivas VR; Departments of Dermatology and Pathology, and Clinical Cancer Genomics Laboratory, University of California, San Francisco, California.
  • Wolff AM; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California.
  • Fraser JS; Departments of Dermatology and Pathology, and Clinical Cancer Genomics Laboratory, University of California, San Francisco, California.
  • Collisson EA; Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, Florida.
  • McCoach CE; Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, Florida.
  • Camidge DR; Department of Medicine, University of California, San Francisco, California.
  • Pacheco J; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, California.
  • Bazhenova L; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, California.
  • Li T; Department of Medicine, University of California, San Francisco, California.
  • Bivona TG; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California.
  • Blakely CM; Department of Medicine, University of California, San Francisco, California.
Clin Cancer Res ; 26(2): 439-449, 2020 01 15.
Article en En | MEDLINE | ID: mdl-31548343
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Proteína Oncogénica p21(ras) / Exones / Carcinoma de Pulmón de Células no Pequeñas / Proteínas Proto-Oncogénicas c-met / Sistema de Señalización de MAP Quinasas / Crizotinib Tipo de estudio: Prognostic_studies Límite: Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Proteína Oncogénica p21(ras) / Exones / Carcinoma de Pulmón de Células no Pequeñas / Proteínas Proto-Oncogénicas c-met / Sistema de Señalización de MAP Quinasas / Crizotinib Tipo de estudio: Prognostic_studies Límite: Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article